ClassID:

115971

C12Y207/07048 - CPC Classification

Classification description:

Transferases transferring phosphorus-containing groups (2.7); Nucleotidyltransferases (2.7.7) RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase

Recent Application in this class:
#1
20260152750
2026-06-04

RNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF

#2
20260109975
2026-04-23

SELF-REPLICATING RNA AND USE THEREOF

#3
20260085338
2026-03-26

PSEUDOMONAS RECOMBINANT PROTEIN EXPRESSION SYSTEM

#4
20250361520
2025-11-27

METHODS AND COMPOSITIONS FOR PRODUCING SELF-AMPLIFYING RNA FOR GENE SILENCING IN PLANTS

#5
20250352641
2025-11-20

METHODS TO INCREASE IMMUNOGENICITY OF RDRP

#6
20250281602
2025-09-11

Replicon Compositions and Methods of Using Same for the Treatment of Diseases

#7
20250270583
2025-08-28

Methods for Suppression of Gene Silencing in Plants

#8
20250230480
2025-07-17

RECOMBINANT VECTOR AND USES THEREOF

#9
20250152736
2025-05-15

IMMUNE SYSTEM MODULATORS AND USES THEREOF

#10
20240417715
2024-12-19

METHODS AND COMPOSITIONS FOR PRIME EDITING RNA

#11
20240294882
2024-09-05

RNA-ONLY DERIVED ORTHOMYXOVIRUSES AND ASSOCIATED VECTORS AND USES THEREOF

#12
20240279705
2024-08-22

EUKARYOTIC CELL LYSATES COMPRISING EXOGENOUS ENZYMES AND METHODS FOR PREPARING THE SAME

#13
20240269256
2024-08-15

COMPOSITIONS AND METHODS FOR ENHANCED ANTIGEN BINDING PROTEINS

#14
20240200042
2024-06-20

LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE

#15
20240123049
2024-04-18

CIS-REPLICON CONSTRUCT

#16
20230295627
2023-09-21

Novel Replicase Cycling Reaction (RCR) and the Related SamRNA Designs Thereof

#17
20220411848
2022-12-29

Novel Replicase Cycling Reaction (RCR)

#18
20220396778
2022-12-15

Novel RNA Composition and Production Method for Use in iPS Cell Generation

#19
20220186271
2022-06-16

Xylose-induced genetically engineered bacteria used for producing ectoine and use thereof

#20
20210369810
2021-12-02

Self-replicating cell selective gene delivery compositions, methods, and uses thereof

#21
20210179656
2021-06-17

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

#22
20200248202
2020-08-06

Copy number variant leading to virus resistance

#23
20200190537
2020-06-18

Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA

#24
20200157571
2020-05-21

Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA

#25
20200157513
2020-05-21

COMPOSITIONS AND METHODS COMPRISING VIRAL REVERSE TRANSCRIPTASE

#26
20200024297
2020-01-23

Substituted nucleosides, nucleotides and analogs thereof

#27
20190330591
2019-10-31

AMPLIFIABLE RNAS FOR THERAPEUTIC CELL SYSTEMS

#28
20180223307
2018-08-09

Copy number variant leading to virus resistance

#29
20180223261
2018-08-09

Attenuated influenza vaccines and uses thereof

#30
20170369903
2017-12-28

Gene expression system using stealthy RNA, and gene introduction/expression vector including said RNA

#31
20170216427
2017-08-03

Coronavirus

#32
20170016022
2017-01-19

Modified gene conferring virus resistance

#33
20170014490
2017-01-19

Methods and materials for reducing the severity of viral infections

#34
20160177319
2016-06-23

Increasing the expression of a transgene in eukaryotic cells by reducing RNA interference

#35
20160176911
2016-06-23

Substituted nucleosides, nucleotides and analogs thereof

#36
20160136260
2016-05-19

Attenuated influenza vaccines and uses thereof

#37
20150315228
2015-11-05

Substituted nucleosides, nucleotides and analogs thereof

#38
20110243910
2011-10-06

MAMMALIAN RNA DEPENDENT RNA POLYMERASE

#39
20070033663
2007-02-08

ES cells having enhanced RNAi effect

#40
20050003541
2005-01-06

ES cells having enhanced RNAi effect

#41
18670452
2025-07-22

Conserved region T cell vaccines for coronavirus and methods of use

#42
17234590
2024-07-02

Conserved region T cell vaccines for coronavirus and methods of use

#43
16247022
2020-07-14

Self-replicating cell selective gene delivery compositions, methods, and uses thereof